Using a mouse model of fully mismatched HSCT and lymphoma, we assess here for the first time the ability of NK cells preactivated with either IL‐12/15/18 or IL‐15 alone to suppress acute GvHD without hampering GvL. The gene discussed is IL15; the disease is graft versus host disease.